Dacogen and Head injury - a phase IV clinical study of FDA data

Summary:

Head injury is reported as a side effect among people who take Dacogen (decitabine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Metformin, and have Myelodysplastic syndrome.

The phase IV clinical study analyzes which people have Head injury when taking Dacogen. It is created by eHealthMe based on reports of 1,535 people who have side effects when taking Dacogen from the FDA, and is updated regularly.

What is Dacogen?

Dacogen has active ingredients of decitabine. eHealthMe is studying from 1,541 Dacogen users. Check the latest studies of Dacogen.

What is Head injury?

Head injury is found to be associated with 2,628 drugs and 3,248 conditions by eHealthMe. Check the latest studies of Head injury.

On Jul, 13, 2026

1,535 people reported to have side effects when taking Dacogen.
Among them, 18 people (1.17%) have Head injury.

Among these 18 people:

How long have people been on Dacogen when they have Head injury? *

What is the gender of people who have Head injury when taking Dacogen? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Head injury when taking Dacogen? *

What are other drugs people take besides Dacogen? *

What are other side effects people have besides Head injury? *

Fatigue (feeling of tiredness): 6 people, 33.33%
Thrombocytopenia (decrease of platelets in blood): 5 people, 27.78%
Cerebral Haemorrhage (bleeding within the brain): 5 people, 27.78%
Nausea (feeling of having an urge to vomit): 4 people, 22.22%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 22.22%
Dizziness: 4 people, 22.22%
Fall: 4 people, 22.22%
Febrile Neutropenia (fever with reduced white blood cells): 4 people, 22.22%
Cough: 3 people, 16.67%
Weight Decreased: 3 people, 16.67%

What are the existing conditions these people have? *

Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 6 people, 33.33%
Depression: 4 people, 22.22%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 16.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 16.67%
Iron Metabolism Disorder: 2 people, 11.11%
Platelet Disorder: 2 people, 11.11%
Glucose Tolerance Impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis): 2 people, 11.11%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 11.11%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 11.11%
Fungal Infection: 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Dacogen and have Head injury?

- Check whether Head injury is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dacogen:

Dacogen (1,541 reports)

Head injury treatments and more:

Head injury (160,560 reports)

Browse all side effects of Dacogen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Head injury:

Head injury (2,628 drugs)

Browse all the conditions that are associated with Head injury:

Head injury (3,248 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on decitabine (the active ingredients of Dacogen) and Dacogen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.